Clinical Trials Browser

INDUSTRY × Kidney Neoplasms × Sorafenib × Clear all

NCT00920816 2022-05-06

Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer

Phase 3 Completed

492 enrolled 17 charts

Kidney Neoplasms

NCT00618982 2015-12-24

Sorafenib Dose Escalation in Renal Cell Carcinoma

Phase 2 Completed

83 enrolled 16 charts

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00398814 2014-02-19

Phase I Study of Perifosine + Sorafenib for Patients With Advanced Cancers

Phase 1 Completed

GastrointestinalGenitourinary

Kidney Neoplasms, Liver Neoplasms, Neoplasms